Expanded Scanner Options for NeuroQuant: Toshiba and Hitachi

Cortechs.ai | Expanded Scanner Options for NeuroQuant: Toshiba and HitachiThe Cortechs.ai Engineering team is very excited to announce that NeuroQuant is now compatible with 1.5T Toshiba and Hitachi MRI scanners. These additional scanner options greatly benefit our customers, offering the ability use NeuroQuant brain segmentation accurately and consistently on these scanners, in addition to 1.5T and 3.0T GE, Philips and Siemens and Toshiba Titian 3T MRI scanners.

Over the past few months, Cortechs.ai engineering team validated the 1.5T Toshiba and Hitachi MRI scanners to ensure accurate and consistent brain segmentation results. The findings were impressive. The both scanners showed excellent image quality and contrast allowing for accurate segmentation, and was found to be on par with other validated vendors.

The incorporation of the 1.5T Toshiba and Hitachi scanners into NeuroQuant scanner compatibility allows physicians and researchers more freedom in MRI scanner choices when using NeuroQuant for additional supportive volumetric data to enrich their clinical treatment planning and disease progression monitoring of patients with neurodegenerative conditions, such as multiple sclerosis, Alzheimer’s disease, epilepsy and traumatic brain injury.

Our updated recommended scanner settings can be found here.

Download Now

Like this post? You might also find these interesting.

Cortechs.ai | Expanded Scanner Options for NeuroQuant: Toshiba and Hitachi

Insights

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.
Scroll to Top